Changes in Sources of Information About the Risks and Benefits of Cannabis in a National Cohort of U.S. Adults From 2017 to 2021
Journal of Studies on Alcohol and Drugs · 2025
DOI: 10.15288/jsad.24-00108 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Studies on Alcohol and Drugs, 2025. Verfasst von Francis Julian L Graham und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of California San Francisco, San Francisco, California. Hauptthemen laut MEDLINE: Cannabis, Marijuana Smoking, Marijuana Use. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
OBJECTIVE: As more U.S. states legalize cannabis, marketing from the cannabis industry and news coverage of cannabis have increased. Sources of information on cannabis can influence beliefs about risks and benefits. Yet, little is known about how the use and influence of specific sources of information have changed over time. METHOD: We conducted a longitudinal study of 5,053 U.S. adults between 2017 and 2021. Participants were asked about sources of information on cannabis risks and benefits and which sources were most influential using a web-based survey at three different time points (2017, 2020, 2021). We evaluated changes in the use/influence of multiple sources of information from 2017 to 2021 and examined interactions with age, cannabis use, and state cannabis legal status. RESULTS: The largest increases in sources of information on cannabis benefits and risks were in the use of health professionals (+5.5% for benefits and +17.4% for risks). The largest declines were in the use of traditional media (television, radio, newspapers) (-12.3% and -11.4%, respectively). The use of cannabis advertisements and dispensaries/other industry sources also significantly increased. Health professionals were the most influential source of information in all three waves regardless of age, cannabis use, or state legal status. CONCLUSIONS: Participants sought information from different sources and increasingly relied on health professionals as a primary source, highlighting the need to train health care providers about cannabis risks and benefits. Although fewer people used traditional media, use of industry sources increased, underscoring the need for accurate cannabis information sources.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- School of Medicine, University of California San Francisco, San Francisco, California.
- Center for Data to Discovery and Delivery Innovation, San Francisco Veterans Affairs (VA) Health Care System, San Francisco, California.
- Northern California Institute for Research and Education, San Francisco, California.
- San Francisco VA Medical Center, San Francisco, California.
- University of California San Francisco, Division of General Internal Medicine and Center for Tobacco Control Research and Education, San Francisco, California.
- Epidemiology in Psychiatry, Columbia University Medical Center, New York, New York.
Zitieren
APA
Graham, F. J. L., Keyhani, S., Ling, P., Pravosud, V., Nguyen, N., Hasin, D. S., & Cohen, B. E. (2025). Changes in Sources of Information About the Risks and Benefits of Cannabis in a National Cohort of U.S. Adults From 2017 to 2021. Journal of Studies on Alcohol and Drugs. https://doi.org/10.15288/jsad.24-00108
Vancouver
Graham FJL, Keyhani S, Ling P, Pravosud V, Nguyen N, Hasin DS, et al. Changes in Sources of Information About the Risks and Benefits of Cannabis in a National Cohort of U.S. Adults From 2017 to 2021. Journal of Studies on Alcohol and Drugs. 2025. doi:10.15288/jsad.24-00108
BibTeX
@article{Graham2025,
author = {Graham, Francis Julian L and Keyhani, Salomeh and Ling, Pamela and Pravosud, Vira and Nguyen, Nhung and Hasin, Deborah S and Cohen, Beth E},
title = {Changes in Sources of Information About the Risks and Benefits of Cannabis in a National Cohort of U.S. Adults From 2017 to 2021},
journal = {Journal of Studies on Alcohol and Drugs},
year = {2025},
doi = {10.15288/jsad.24-00108}
}
EUVIMED